Your browser doesn't support javascript.
loading
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Harada, Kaito; Morita-Fujita, Mari; Fukuda, Takahiro; Ozawa, Yukiyasu; Doki, Noriko; Toyosaki, Masako; Maruyama, Yumiko; Kanda, Yoshinobu; Ashida, Takashi; Eto, Tetsuya; Takada, Satoru; Uchida, Naoyuki; Ichinohe, Tatsuo; Kanda, Junya; Onizuka, Makoto; Atsuta, Yoshiko; Kako, Shinichi; Arai, Yasuyuki.
Afiliação
  • Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Morita-Fujita M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Aichi, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Toyosaki M; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Ashida T; Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital, Osaka, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: ysykrai@kuhp.kyoto-u.ac.jp.
Cytotherapy ; 24(9): 954-961, 2022 09.
Article em En | MEDLINE | ID: mdl-35534419
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article